𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with langerhans cell histiocytosis

✍ Scribed by Broadbent, Valerie ;Gadner, Helmut ;Komp, Diane M. ;Ladisch, Stephan

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
348 KB
Volume
17
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Langerhans cell histiocytosis (LCH) has Society. Adoption of a uniform clinical/labopresented problems in diagnosis and in ratory approach to these children, coupled treatment.Thedefinitivediagnosis isapatho-with agreed-upon steps to the pathologic logic one. To advance thorough and uni-identification of LCH, should result in a betform assessment of these patients, the ele-ter understanding and ultimately better and ments of a complete clinical and laboratory more rational therapies for the disease. evaluation are presented by the Histiocyte histiocytosis, Langerhans cell From the Clinical Working Group who met in Cambridge in March 1988. Members include Drs. V. Broadbent, A. Ceci, A. Chu, G.

📜 SIMILAR VOLUMES

“Etoposide in the treatment of six child
“Etoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X)” by Viana et al.
✍ Whitlock, James A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt

Cytosine-arabinoside, vincristine, and p
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated langerhans cell histiocytosis with organ dysfunction: Experience at a single institution
✍ Egeler, R. Maarten ;De Kraker, Jan ;Vo??te, P. A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB

## Abstract Fifty‐two pediatric patients with Langerhans cell histiocytosis (LCH) were diagnosed at the Emma Kinderziekenhuis (EKZ) in Amsterdam over a 20‐year period. Eight patients with multiorgan involvement with organ dysfunction and ten patients with multiorgan involvement without organ dysfun

Langerhans cell histiocytosis patients h
Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter
✍ McClain, Kenneth L. ;Laud, Purnima ;Wu, Wen-Shu ;Pollack, Marilyn S. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract ## Background Current theory on the etiology of Langerhans cell histiocytosis (LCH), formerly Histiocytosis‐X, is that abnormality(ies) of the immune system are responsible for dysregulation of Langerhans cells (LC) in patients' lesions. Among the known abnormalities in LCH patients ar